These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 6744292

  • 1. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
    Lee KH, el Kouni MH, Chu HS, Cha S.
    Cancer Res; 1984 Sep; 44(9):3744-8. PubMed ID: 6744292
    [Abstract] [Full Text] [Related]

  • 2. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.
    Niedzwicki JG, Chu SH, el Kouni MH, Rowe EC, Cha S.
    Biochem Pharmacol; 1982 May 15; 31(10):1857-61. PubMed ID: 7104017
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
    Naguib FN, el Kouni MH, Chu SH, Cha S.
    Biochem Pharmacol; 1987 Jul 01; 36(13):2195-201. PubMed ID: 3606636
    [Abstract] [Full Text] [Related]

  • 7. Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.
    Liu M, Cao D, Russell R, Handschumacher RE, Pizzorno G.
    Cancer Res; 1998 Dec 01; 58(23):5418-24. PubMed ID: 9850074
    [Abstract] [Full Text] [Related]

  • 8. Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine.
    Darnowski JW, Handschumacher RE, Wiegand RA, Goulette FA, Calabresi P.
    Biochem Pharmacol; 1991 Jun 15; 41(12):2031-6. PubMed ID: 2039551
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
    Belt JA.
    Mol Pharmacol; 1983 Nov 15; 24(3):479-84. PubMed ID: 6314117
    [Abstract] [Full Text] [Related]

  • 10. Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine.
    Martin DS, Stolfi RL, Sawyer RC.
    Cancer Chemother Pharmacol; 1989 Nov 15; 24(1):9-14. PubMed ID: 2720896
    [Abstract] [Full Text] [Related]

  • 11. Species-dependent differences in the biochemical effects and metabolism of 5-benzylacyclouridine.
    Davis ST, Joyner SS, Chandrasurin P, Baccanari DP.
    Biochem Pharmacol; 1993 Jan 07; 45(1):173-81. PubMed ID: 8424810
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy.
    Sommadossi JP, Cretton EM, Kidd LB, McClure HM, Anderson DC, el Kouni MH.
    Cancer Chemother Pharmacol; 1995 Jan 07; 37(1-2):14-22. PubMed ID: 7497584
    [Abstract] [Full Text] [Related]

  • 15. Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources.
    Drabikowska AK, Lissowska L, Veres Z, Shugar D.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4125-8. PubMed ID: 3318842
    [Abstract] [Full Text] [Related]

  • 16. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
    Temmink OH, de Bruin M, Turksma AW, Cricca S, Laan AC, Peters GJ.
    Int J Biochem Cell Biol; 2007 Dec 01; 39(3):565-75. PubMed ID: 17098463
    [Abstract] [Full Text] [Related]

  • 17. Tissue-specific enhancement of uridine utilization and 5-fluorouracil therapy in mice by benzylacyclouridine.
    Darnowski JW, Handschumacher RE.
    Cancer Res; 1985 Nov 01; 45(11 Pt 1):5364-8. PubMed ID: 4053009
    [Abstract] [Full Text] [Related]

  • 18. Benzylacyclouridine. Pharmacokinetics, metabolism and biochemical effects in mice.
    Darnowski JW, Handschumacher RE.
    Biochem Pharmacol; 1988 Jul 01; 37(13):2613-8. PubMed ID: 3390221
    [Abstract] [Full Text] [Related]

  • 19. Facilitated transport of inosine and uridine in cultured mammalian cells is independent of nucleoside phosphorylases.
    Plagemann PG, Wohlhueter RM, Erbe J.
    Biochim Biophys Acta; 1981 Jan 22; 640(2):448-62. PubMed ID: 6783140
    [Abstract] [Full Text] [Related]

  • 20. Uptake of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) and analogues by the facilitated transport mechanism of erythrocytes.
    Monks A, Marquez VE, Mao DT, Cysyk RL.
    Cancer Lett; 1985 Aug 22; 28(1):1-8. PubMed ID: 4027951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.